Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:22 pm Purchase | 2024-09-30 | 13G | RedHill Biopharma Ltd. RDHL | CVI Investments, Inc. | 672,549,217 4.900% | 672,549,217 (New Position) | Filing History |
| 2024-08-07 4:43 pm Unchanged | 2024-03-22 | 13D | RedHill Biopharma Ltd. RDHL | Quintairos, Prieto, Wood & Boyer P.A. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-02 4:10 pm Purchase | 2024-01-25 | 13G | RedHill Biopharma Ltd. RDHL | Mitchell P. Kopin | 2,000 4.000% | 2,000 (New Position) | Filing History |
| 2024-02-01 10:22 am Purchase | 2024-01-25 | 13G | RedHill Biopharma Ltd. RDHL | CVI Investments, Inc. | 1,120,000 5.900% | 1,120,000 (New Position) | Filing History |
| 2024-01-08 10:23 am Purchase | 2023-12-31 | 13G | RedHill Biopharma Ltd. RDHL | Empery Asset Management, LP | 414,607 3.190% | 414,607 (New Position) | Filing History |
| 2024-01-02 4:26 pm Sale | 2023-12-31 | 13G | RedHill Biopharma Ltd. RDHL | SABBY MANAGEMENT LLC | 0 0.000% | -12,065 (Position Closed) | Filing History |
| 2023-01-13 08:04 am Purchase | 2022-12-31 | 13G | RedHill Biopharma Ltd. RDHL | Empery Asset Management, LP | 6,200 6.120% | 6,200 (New Position) | Filing History |
| 2023-01-04 09:09 am Purchase | 2022-12-31 | 13G | RedHill Biopharma Ltd. RDHL | SABBY MANAGEMENT LLC | 302 11.000% | 302 (New Position) | Filing History |
| 2022-03-07 5:25 pm Purchase | 2019-10-17 | 13G | RedHill Biopharma Ltd. RDHL | Cosmo Pharmaceuticals N.V. | 2,760 13.200% | 2,760 (New Position) | Filing History |
| 2022-01-27 4:31 pm Sale | 2021-12-31 | 13G | RedHill Biopharma Ltd. RDHL | Ibex Investors LLC | 52 0.300% | -859 (-94.24%) | Filing History |
| 2021-01-15 11:19 am Purchase | 2020-12-31 | 13G | RedHill Biopharma Ltd. RDHL | Ibex Investors LLC | 911 5.500% | 203 (+28.68%) | Filing History |